...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: A few thoughts
6
bfw
Nov 16, 2019 12:52PM

Thanks bfw! I'll just re-post my thoughts to your message.

The forest plot looks amazing. Benefit clearly trending in the right direction for everything except there was no effect on stroke. 

As expected, apabetalone increased HDL-C and decreased alkaline phosphatase. 

No statin synergy on 3-point MACE.

Biggest thing that caught my eye was 50% RRR for 3-point MACE in those patients w/ baseline eGFR<60. 

No significant effects on glucose, HbA1c or LDL-C, though these increased more in the placebo than apabetalone groups. No difference in hsCRP.

4
Nov 16, 2019 01:26PM
1
Nov 16, 2019 01:28PM
4
Nov 16, 2019 01:39PM
1
Nov 16, 2019 01:42PM
7
bfw
Nov 16, 2019 01:42PM
6
Nov 16, 2019 01:57PM
2
Nov 16, 2019 02:03PM
7
Nov 16, 2019 02:22PM
2
Nov 16, 2019 02:25PM
5
Nov 16, 2019 02:34PM
4
Nov 16, 2019 02:35PM
6
Nov 16, 2019 02:53PM
3
Nov 16, 2019 03:38PM
2
Nov 16, 2019 06:10PM
5
Nov 16, 2019 06:40PM
5
Nov 16, 2019 07:17PM
5
Nov 17, 2019 05:42PM
2
Nov 17, 2019 05:49PM
1
Nov 18, 2019 05:21AM
Share
New Message
Please login to post a reply